noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Healthcare

Novavax Inc.

Novavax Submits Application to Health Canada for Updated Protein based[...]
Vertex Pharmaceuticals Incorporated

Vertex Announces FDA Acceptance of New Drug Application for[...]
Veru Inc.

Veru to Participate in the Leerink Therapeutics Forum: I&I and Metabolism

Johnson & Johnson

07/02/2024 | Press release | Distributed by Public on 07/02/2024 06:31

CARVYKTI® (ciltacabtagene autoleucel) achieved statistically significant and clinically meaningful improvement in overall survival in landmark CARTITUDE-4 study

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | Johnson & Johnson | News | Health | Securities Issuers | Pharmaceutical Companies | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Frankfurt Stock Exchange | Six Swiss Exchange | Sao Paulo Stock Exchange (B3) | Vienna Stock Exchange (ATX) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Hamburg Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Santiago Stock Exchange | Bolsa Mexicana de Valores (BMV) | Buenos Aires Stock Exchange (BCBA) | Lima Stock Exchange (BVL) | Colombia Securities Exchange | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | Bolsa Electrónica de Chile | Cboe BZX Exchange | Cboe BXE Europe | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | Investors Exchange (IEX) | EuroTLX | Bolsa Institucional de Valores (BIVA) | Hannover Stock Exchange | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago | Turquoise

Back

Download the original document